liver malignant
Conditions
Interventions
Trial group:multimode tumor ablation therapy
Sponsors
Fudan University Shanghai Cancer Center
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Adults aged 18 years to 80 years of either gender; 2. Histologically confirmed or clinically diagnosed liver malignant tumor, including primary liver cancer and secondary liver cancer; 3. The liver lesion planning to ablation can be evaluated by imaging. No more than 5 lesions and smaller than 4.0 cm each; 4. The patient cannot tolerate or refuses to undergo surgical resection; 5. The physical status score of ECOG <= 2, and life expectancy longer than 3 months.
Exclusion criteria
Exclusion criteria: 1. Liver function classified as Child-Pugh C, or severe jaundice, especially obstructive jaundice; 2. Diffuse liver cancer; or tumor invading the main/secondary branch of portal vein; or combined with hepatic vein tumor thrombus; 3. Estimated ablation region reach to 1/3 of the liver volume caused by large tumor or significant liver atrophy. 4. Multiple systemic metastases, with an expected survival period of 1 level). 12. Any remaining factor considered not suitable for radiofrequency ablation according to the discussion of investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary efficacy rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| The rate of complications;The accuracy of ablation;The stability of system; | — |
Countries
China
Contacts
Public ContactWang Guangzhi
Outcome results
None listed